STE logo

STERIS (STE)

Profile

Full Name

STERIS plc

Ticker Symbol

STE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

June 1, 1992

Indexes

S&P 500

Website

http://www.steris.com

Employees

18000

Key Details

Price

$221.04(-1.33%)

Market cap

Last Dividend

$0.57

TTM Dividend yield

1.01%

Annual revenue

$5.14B(+13.28% YoY)

Annual EPS

$3.81(+256.07% YoY)

PE ratio

46.93

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$221.04
STE price is $221.04

30-Day Relative Volume

0.53
STE 30-day relative volume is 0.53

Price Performance

Price Today change

-1.33%
STE price is down -1.33% today

Price YTD change

+7.53%
STE price is up +7.53% since January 1st

Price 1-year change

+9.86%
STE price is up +9.86% year-on-year

Price 3-year change

-9.58%
STE price is down -9.58% over the past 3 years

Price Range

Price All-time high

$255.93
STE price is currently -13.63% below its historical high of $255.93

Price 3-year low

$159.21
STE price is currently +38.84% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$21.72B
STE market capitalization is $21.72 billion

Market cap 3-year change

-11.22%
STE market capitalization is down -11.22% over the past 3 years

Market cap All-time high

$25.31B
STE market capitalization is currently -14.19% below its historical high of $25.31 billion

Market cap sector rank

95.89%
STE market capitalization is higher than 95.89% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.64%
STE shares outstanding is down -0.64% year-on-year

Shares Outstanding 3-Year Change

-1.81%
STE shares outstanding is down -1.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.50
STE beta is 0.50

200-day SMA

$224.19
STE price is currently -1.41% below its 200-day simple moving average

50-day SMA

$222.89
STE price is currently -0.83% below its 50-day simple moving average

RSI

49.52
STE 14-day relative strength index is 49.52

Volume

0.53
STE 30-day relative volume is 0.53

ATR

$7.39
STE average true range is $7.39

10-day Historical Volatility

49.84%
STE 10-day historical volatility is 49.84%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.57
STE last dividend was $0.57 per share, with an ex-dividend date of February 20, 2025

Next Dividend

-
STE next dividend has not yet been announced

Dividend per share

Dividend per share

$2.03
STE annual dividend per share is $2.03

Dividend per share Sector Rank

70.93%
STE annual dividend per share is higher than 70.93% of companies in Healthcare sector

Dividend per share 1-Year Change

+10.33%
STE annual dividend per share is up +10.33% year-on-year

Dividend per share 3-Year Change

+29.3%
STE annual dividend per share is up +29.3% over the past 3 years

Dividend yield

Dividend yield

0.92%
STE annual dividend yield is 0.92%

Dividend yield Sector Rank

28.24%
STE annual dividend yield is higher than 28.24% of companies in Healthcare sector

Other

Payout ratio

53.03%
STE annual payout ratio is 53.03%

Dividends paid

$200.57M
STE annual dividends paid is $200.57 million

Free cash flow

$612.95M
STE annual free cash flow is $612.95 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.14B
STE annual revenue is $5.14 billion

Revenue Analysts estimate

$5.45B
STE annual revenue is currently -5.68% lower than the consensus analysts' forecast

Revenue 1-year change

+13.28%
STE annual revenue is up +13.28% year-on-year

Revenue Sector rank

91.94%
STE annual revenue is higher than 91.94% of companies in Healthcare sector

EPS

EPS

$3.81
STE annual earnings per share is $3.81

EPS Analysts estimate

$9.05
STE annual earnings per share is currently -57.91% lower than the consensus analysts' forecast

EPS 1-year change

+256.07%
STE annual earnings per share is up +256.07% year-on-year

EPS Sector rank

94.71%
STE annual earnings per share is higher than 94.71% of companies in Healthcare sector

Profit

Gross profit

$2.22B
STE annual gross profit is $2.22 billion

Gross margin

43.17%
STE annual gross profit margin is 43.17%

Operating profit

$862.16M
STE annual operating income is $862.16 million

Operating margin

16.78%
STE annual operating profit margin is 16.78%

Net income

$378.24M
STE annual net profit is $378.24 million

Net margin

7.36%
STE annual net profit margin is 7.36%

Expenses

Total expenses

$4.28B
STE annual total expenses is $4.28 billion

Operating expenses

$1.36B
STE annual total operating expenses is $1.36 billion

Cost of goods sold

$2.92B
STE annual cost of goods sold is $2.92 billion

Selling, general & administrative expenses

$1.25B
STE annual SGA is $1.25 billion

Depreciation and amortization

-
STE annual depreciation & amortization value is unknown

Interest expense

$144.35M
STE annual interest expense is $144.35 million

Income tax

$149.53M
STE annual income tax is $149.53 million

EBIT & EBITDA

EBIT

$862.16M
STE annual earnings before interest & taxes is $862.16 million

EBITDA

$862.16M
STE annual EBITDA is $862.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.06B
STE annual total assets is $11.06 billion

Non current assets

$8.20B
STE annual long term assets is $8.20 billion

Current assets

$2.88B
STE annual total current assets is $2.88 billion

Cash and cash equivalents

$207.02M
STE annual cash & cash equivalents is $207.02 million

Accounts receivable

$1.01B
STE annual accounts receivable is $1.01 billion

Inventory

$674.53M
STE annual inventory is $674.53 million

Liabilities

Total liabilities

$4.75B
STE annual total liabilities is $4.75 billion

Long term liabilities

$3.82B
STE annual total long term liabilities is $3.82 billion

Current liabilities

$939.27M
STE annual total current liabilities is $939.27 million

Accounts payable

$251.72M
STE annual accounts payable is $251.72 million

Debt

Total debt

$3.24B
STE annual total debt is $3.24 billion

Total debt 1-year change

-0.97%
STE annual total debt is down -0.97% year-on-year

Long term debt

$3.12B
STE annual long term debt is $3.12 billion

Short term debt

$117.18M
STE annual short term debt is $117.18 million

Equity & Capital

Shareholders equity

$6.30B
STE annual stockholders equity is $6.30 billion

Book value

$6.32B
STE annual book value is $6.32 billion

Retained earnings

$2.09B
STE annual retained earnings is $2.09 billion

Working capital

$1.94B
STE annual working capital is $1.94 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$973.27M
STE annual cash flow from operations is $973.27 million

Cash from operations 1-year change

+28.58%
STE annual cash flow from operations is up +28.58% year-on-year

Cash from investing

-$887.36M
STE annual cash flow from investing activities is -$887.36 million

Cash from investing 1-year change

-131.49%
STE annual cash flow from investing activities is down -131.49% year-on-year

Cash from financing

-$85.19M
STE annual cash flow from financing activities is -$85.19 million

Cash from financing 1-year change

+82.92%
STE annual cash flow from financing activities is up +82.92% year-on-year

CAPEX

CAPEX

$360.33M
STE annual capital expenditures is $360.33 million

CAPEX 1-year change

-0.45%
STE annual capital expenditures is down -0.45% year-on-year

Free Cash Flow

Free cash flow

$612.95M
STE annual free cash flow is $612.95 million

Free cash flow 1-year change

+55.19%
STE annual free cash flow is up +55.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

43.17%
STE annual gross profit margin is 43.17%

Operating margin

16.78%
STE annual operating profit margin is 16.78%

Net margin

7.36%
STE annual net profit margin is 7.36%

ROA & ROE

ROA

3.46%
STE annual return on assets is 3.46%

ROE

6.10%
STE annual return on equity is 6.10%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

46.93
STE price to earnings ratio is 46.93

PE ratio Sector rank

76.96%
STE price to earnings ratio is higher than 76.96% of companies in Healthcare sector

PB Ratio

PB ratio

3.38
STE price to book ratio is 3.38

PB ratio Sector rank

74.81%
STE price to book ratio is higher than 74.81% of companies in Healthcare sector

PS Ratio

PS ratio

4.02
STE price to sales ratio is 4.02

PS ratio Sector rank

61.79%
STE price to sales ratio is higher than 61.79% of companies in Healthcare sector

Enterprise value

Enterprise value

$23.88B
STE enterprise value is $23.88 billion

Enterprise value Sector rank

95.54%
STE enterprise value is higher than 95.54% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.63
STE EV/EBITDA is 18.63

EV/EBITDA Sector rank

90.78%
STE EV/EBITDA is higher than 90.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.06
STE annual current ratio is 3.06

Quick ratio

2.34
STE annual quick ratio is 2.34

Leverage

Debt to equity

0.49
STE annual debt to equity ratio is 0.49

Interest coverage ratio

5.97
STE annual interest coverage ratio is 5.97

Risk & Stability

Piotroski F-Score

8
STE piotroski f-score is 8

Altman Z-Score

3.94
STE altman z-score is 3.94

Analyst ratings

Recent major analysts updates

Apr 10, 25 JMP Securities
Market Outperform
Apr 7, 25 Needham
Hold
Feb 6, 25 Stephens & Co.
Overweight
Feb 6, 25 JMP Securities
Market Outperform
Feb 3, 25 Piper Sandler
Overweight
Nov 18, 24 JMP Securities
Market Outperform
Nov 8, 24 Needham
Hold
Nov 7, 24 Stephens & Co.
Overweight
Oct 24, 24 Piper Sandler
Overweight
Aug 8, 24 Needham
Hold

Institutional Ownership

Similar stocks

MTD logo
Mettler-Toledo International (MTD)
PHG logo
Koninklijke Philips NV (PHG)
NTRA logo
Natera (NTRA)
BNTX logo
BioNTech SE (BNTX)
ZBH logo
Zimmer Biomet Holdings (ZBH)
WAT logo
Waters (WAT)
LH logo
Laboratory Corporation of America Holdings (LH)
MOH logo
Molina Healthcare (MOH)
DGX logo
Quest Diagnostics Incorporated (DGX)
  • What is the ticker symbol for STERIS?
  • Does STERIS pay dividends?
  • What sector is STERIS in?
  • What industry is STERIS in?
  • What country is STERIS based in?
  • When did STERIS go public?
  • Is STERIS in the S&P 500?
  • Is STERIS in the NASDAQ 100?
  • Is STERIS in the Dow Jones?
  • When was STERIS's last earnings report?
  • When does STERIS report earnings?
  • Should I buy STERIS stock now?

What is the ticker symbol for STERIS?

The ticker symbol for STERIS is NYSE:STE

Does STERIS pay dividends?

Yes, STERIS pays dividends. The last payment was $0.57, with an ex-dividend date on February 20, 2025

What sector is STERIS in?

STERIS is in the Healthcare sector

What industry is STERIS in?

STERIS is in the Medical Devices industry

What country is STERIS based in?

STERIS is headquartered in United States

When did STERIS go public?

STERIS's initial public offering (IPO) was on June 1, 1992

Is STERIS in the S&P 500?

Yes, STERIS is included in the S&P 500 index

Is STERIS in the NASDAQ 100?

No, STERIS is not included in the NASDAQ 100 index

Is STERIS in the Dow Jones?

No, STERIS is not included in the Dow Jones index

When was STERIS's last earnings report?

STERIS's most recent earnings report was on Feb 5, 2025

When does STERIS report earnings?

The next expected earnings date for STERIS is May 8, 2025

Should I buy STERIS stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page